Novel mas receptor agonists for chronic neuropathic pain and vascular dementia
ProNeurogen's lead compounds (PNA1, PNA5, PNA6) are rationally designed Mas receptor agonists that inhibit inflammatory pathways in the brain and cerebrovasculature. PNA5 targets chronic neuropathic pain and vascular cog...